Clinical Trial Liaison

Clinical Trial Liaison (CTL) – Phase III Oncology

We are currently seeking an experienced Clinical Trial Liaison (CTL) to support Phase III oncology clinical development programs.

This is a field-based, non-promotional clinical role focused on strengthening relationships with investigators and research sites, supporting enrollment and retention, improving protocol understanding, and providing valuable insights to the clinical development team.

• Build and maintain strong relationships with investigators, KOLs, research staff, and referring healthcare professionals.
• Provide balanced, non-promotional education on disease state, study rationale, protocol requirements, eligibility criteria, and study procedures.
• Identify and help address site-specific enrollment, recruitment, referral, and operational barriers.
• Support investigator meetings, site training, enrollment reviews, and other study activities.
• Identify potential academic and community sites with relevant patient populations and clinical trial capabilities.
• Help develop and strengthen patient referral pathways.
• Gather and communicate field insights around patient flow, recruitment challenges, protocol feasibility, site needs, and competing studies.
• Collaborate closely with Clinical Development, Clinical Operations, Medical Affairs, Patient Advocacy, and CRA teams.
• Escalate medical, safety, regulatory, or protocol-related questions to the appropriate Sponsor team.

• PharmD, PhD, MD, or equivalent advanced scientific degree in a life science discipline.
• 8+ years of pharmaceutical or biotech industry experience.
• At least 2 years of field-based medical experience.
• Strong understanding of oncology disease states, treatment paradigms, and the current scientific landscape.
• Proven experience engaging with KOLs, investigators, and healthcare professionals.
• Excellent scientific communication, presentation, and relationship-building skills.
• Strong ability to work independently while collaborating within a cross-functional, matrixed environment.

Experience with investigational oncology products, early-stage biotech, GCP/ICH standards, medical information systems, or CRM platforms.